Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.

Company Data

Name Bellevue Life Sciences Acquisition Corp. - Common Stock

Company Bellevue Life Sciences Acquisition Corp.

Symbol BLAC

Website https://www.bellevuespac.com

Primary Exchange

NASDAQ

ISIN US0791741087

Asset Class Share

Sector Financial Services

Industry Shell Companies

CEO Kuk Hyoun Hwang

Country United States of America

Currency USD

Employees -

Address 10900 NE 4th Street, 98004 Bellevue

IPO Date 2023-03-21

Ticker Symbols

Name	Symbol
NASDAQ	BLAC

More Shares

Investors who hold Bellevue Life Sciences Acquisition Corp. - Common Stock also have the following shares in their portfolio:

Accelleron Industries AG Share

VINCI S.A. 18/30 MTN Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog